Australia markets closed

Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
21.65-0.32 (-1.46%)
At close: 03:04PM CST

Hefei Lifeon Pharmaceutical Co., Ltd.

Cube Factory
No. 669 Changjiang West Road
Hefei 230088
China
86 551 6535 0389
https://www.lifeonapi.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees1,219

Key executives

NameTitlePayExercisedYear born
Ms. Xiaojuan DengVice Chairman of the Board & GMN/AN/A1965
Mr. Shaobing GouFinancial DirectorN/AN/A1977
Mr. Xueyu XuDeputy General ManagerN/AN/A1964
Mr. Jun ChenR&D Director & Non-Independent DirectorN/AN/A1963
Mr. Tianhe DaiDeputy General ManagerN/AN/A1977
Mr. Jun XiaDeputy GM & Secretary of the BoardN/AN/A1983
Ms. Qing WangDeputy GM & Non-Independent DirectorN/AN/A1967
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. It operates through Pharmaceutical Industry, Pharmaceutical Wholesale and Distribution, and Pharmaceutical Retail Business segments. The company offers active pharmaceutical ingredients, which include nifedipine, paliperidone, prilocaine, methylphenidate hydrochloride, dimercaptosuccinic acid, doxazosin mesylate, paeonol, urea, felodipine, and troxerutin; and medical preparations, such as osmotic pump preparations, central nervous systems, Chinese patent medicines, eye drops, external use, and general oral medicines. In addition, it provides medical intermediates, including 3-methoxy-1 propanethiol, mercaptosuccinic acid, domiphene, sodium dimercaptosulfonate, 3-mercapto-1-propanol, paeonol, sodium paeonol sulfonate, methyl 2,3-dichlorobenzylidene acetoacetate, n-[(1,4-benzodioxan-2-yl) carbonyl piperazine hydrochloride, alogliptin benzoate, roflumilast, and zofenopril calcium; plant extract products, such as clove oil and campanula extracts; and pieces that consist of poria decoction, astragalus, honeysuckle, rose, and phellinus decoction. Further, the company offers central nervous system drugs, cardiovascular drugs, digestive system drugs, ophthalmic drugs, external skin drugs and other fields. Hefei Lifeon Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Hefei, China.

Corporate governance

Hefei Lifeon Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.